手术台看不见血点，打破日企30年垄断，被欧美称为等待10年的技术

Core Insights - The article highlights the breakthrough of a Chinese-developed endoscope system utilizing "red light" technology, which addresses critical challenges in identifying bleeding points during surgeries, thus breaking a 30-year monopoly held by Japanese companies [6][8]. Industry Challenges - The endoscope market in China is dominated by Japanese firms, with Olympus and other companies holding 80% of the soft endoscope market share [3]. - The National Cancer Center reported that in 2022, there were 480,000 new stomach cancer cases and 320,000 esophageal cancer cases in China, accounting for 30% to 40% of global patients, emphasizing the need for standardized endoscopic examinations [3]. Technological Advancements - The newly developed DHI red light imaging technology enhances the contrast between deep blood vessels and blood, allowing for quick identification of bleeding points during surgeries [10][12]. - The system incorporates a full-scene imaging solution, including HLI true color white light and TCI color separation, which significantly improves the detection of early cancer cells and bleeding points [14][17]. Competitive Advantages - Lingmou Medical's endoscope system is priced at 60% lower than imported devices, making it more accessible for grassroots hospitals [19]. - The company offers rapid local support and training, with a 48-hour parts delivery guarantee, which is a significant advantage over international competitors [19]. Market Expansion - Lingmou Medical's sales exceeded tens of millions in the first half of 2025, with products being exported to 20 countries, including Malaysia, where it is referred to as the "no-blood surgical device" [20]. - The company plans to launch a 145x optical magnification endoscope in Europe by the end of 2025, showcasing its commitment to innovation and market growth [21]. Training and Implementation - The company has conducted 27 hands-on training sessions in county-level hospitals, enabling local doctors to perform complex procedures independently, thus improving healthcare capabilities in underserved areas [22][23].